Jeremy Miles
Overview
Explore the profile of Jeremy Miles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flom P, Harron K, Ballesteros J, Kalinda C, Koutoumanou E, Miles J, et al.
BMJ Paediatr Open
. 2024 Sep;
8(1).
PMID: 39284617
As statistical reviewers and editors for BMJ Paediatrics Open (BMJPO), we frequently see methodological and statistical errors in articles submitted to our journal. To make a list of these common...
2.
Peterson B, Trampush J, Brown M, Maglione M, Bolshakova M, Rozelle M, et al.
Pediatrics
. 2024 Mar;
153(4).
PMID: 38523599
Context: Correct diagnosis is essential for the appropriate clinical management of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents. Objective: This systematic review provides an overview of the available diagnostic tools....
3.
Peterson B, Trampush J, Maglione M, Bolshakova M, Rozelle M, Miles J, et al.
Pediatrics
. 2024 Mar;
153(4).
PMID: 38523592
Context: Effective treatment of attention-deficit/hyperactivity disorder (ADHD) is essential to improving youth outcomes. Objectives: This systematic review provides an overview of the available treatment options. Data Sources: We identified controlled...
4.
Pina P, Lorenzatti D, Castagna F, Miles J, Kuno T, Scotti A, et al.
J Clin Lipidol
. 2024 Feb;
18(3):e403-e412.
PMID: 38368138
Background: Coronary artery calcium (CAC), thoracic aorta calcification (TAC), non-alcoholic fatty liver disease (NAFLD), and epicardial adipose tissue (EAT) are associated with atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF)....
5.
Miles J, Scotti A, Castagna F, Kuno T, Leone P, Coisne A, et al.
Circulation
. 2023 Nov;
149(6):417-426.
PMID: 37970713
Background: Tools for mortality prediction in patients with the severe hypercholesterolemia phenotype (low-density lipoprotein cholesterol ≥190 mg/dL) are limited and restricted to specific racial and ethnic cohorts. We sought to...
6.
Pina P, Fernandez C, Lorenzatti D, Castagna F, Miles J, Kuno T, et al.
Prog Cardiovasc Dis
. 2023 Nov;
81:105-108.
PMID: 37926153
No abstract available.
7.
Castagna F, Miles J, Arce J, Leiderman E, Neshiwat P, Ippolito P, et al.
Circ Cardiovasc Imaging
. 2022 Jun;
15(6):e014135.
PMID: 35727870
Background: Current guidelines recommend coronary artery calcium (CAC) scoring for stratification of atherosclerotic cardiovascular disease risk only in patients with borderline to intermediate risk score by the pooled cohort equation...
8.
Katamreddy A, Kokkinidis D, Miles J, Siasos G, Giannakoulas G, Faillace R
Rev Cardiovasc Med
. 2022 Mar;
23(2):51.
PMID: 35229542
Background: Although red cell distribution width (RDW) is associated with increased cardiovascular mortality, the relationship between an elevated RDW and cardiovascular mortality among various ASCVD risk groups is unknown. Methods:...
9.
Katamreddy A, Uppal D, Ramani G, Rios S, Miles J, Wang Y, et al.
J Clin Sleep Med
. 2021 Sep;
18(3):921-926.
PMID: 34534068
Study Objectives: There is a paucity of data on the association between day-to-day variation in sleep pattern and all-cause mortality. We aimed to investigate whether day-to-day variation in sleep duration...
10.
Friedman A, Miles J, Liebelt J, Christia P, Engstrom K, Thachil R, et al.
Cureus
. 2021 Mar;
13(1):e12895.
PMID: 33643739
Background Amiodarone causes less drug-induced torsade de pointes (TdP) compared to other class III antiarrhythmics. Two theories proposed for this finding include that amiodarone has less repolarization heterogeneity, and/or decreases...